Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Mundipharma AB |
---|---|
Information provided by: | Mundipharma AB |
ClinicalTrials.gov Identifier: | NCT00399178 |
To evaluate the efficacy and safety of Norspan versus Tiperol Retard among OA patients who are sub-optimally treated with current analgesic. Those patients may benefit from treatment with a long lasting analgesic.
Condition | Intervention | Phase |
---|---|---|
Osteoarthritis |
Drug: Transdermal delivery system |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study |
Official Title: | A Randomised Open Controlled Parallel Group Multicenter Study to Evaluate the Efficacy and Safety of Norspan Versus Tiparol Retard in Subjects With Chronic Moderate to Severe OA Pain of the Hip and/or Knee. |
Estimated Enrollment: | 160 |
Study Start Date: | November 2006 |
Study Completion Date: | June 2007 |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | 2006-003233-32, BUP4009 |
Study First Received: | November 10, 2006 |
Last Updated: | August 16, 2007 |
ClinicalTrials.gov Identifier: | NCT00399178 History of Changes |
Health Authority: | Sweden: Medical Products Agency |
Osteoarthritis Norspan versus Tramadol Randomised Efficacy and safety OA pain of the hip and/or knee |
Musculoskeletal Diseases Tramadol Osteoarthritis Joint Diseases |
Arthritis Pain Rheumatic Diseases |
Musculoskeletal Diseases Osteoarthritis Joint Diseases Arthritis Rheumatic Diseases |